Treatment of Kleine-Levin Syndrome: Melatonin on the Starting Block
J Clin Psychiatry 2000;61(3):215 [letter]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Letter to the Editor
Sir: Kleine-Levin syndrome (KLS) is complex and rare,
primarily affects adolescent males, and is characterized by recurrent
attacks of hypersomnia, excessive eating, and striking
behavioral and psychiatric symptoms. It has been hypothesized
that KLS is related to bipolar affective spectrum disorders.
Exogenous melatonin administration does not seem to improve
patients with rapid-cycling bipolar disorder. This treatment,
however, has not yet been tested in KLS. We report a case of a
man with persistent KLS symptoms that were alleviated after
treatment with exogenous melatonin.